Correlation Between Evolus and Cannara Biotech
Can any of the company-specific risk be diversified away by investing in both Evolus and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Cannara Biotech, you can compare the effects of market volatilities on Evolus and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Cannara Biotech.
Diversification Opportunities for Evolus and Cannara Biotech
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Evolus and Cannara is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Evolus i.e., Evolus and Cannara Biotech go up and down completely randomly.
Pair Corralation between Evolus and Cannara Biotech
Given the investment horizon of 90 days Evolus Inc is expected to under-perform the Cannara Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Evolus Inc is 1.63 times less risky than Cannara Biotech. The stock trades about -0.04 of its potential returns per unit of risk. The Cannara Biotech is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 58.00 in Cannara Biotech on September 2, 2024 and sell it today you would lose (7.00) from holding Cannara Biotech or give up 12.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evolus Inc vs. Cannara Biotech
Performance |
| Timeline |
| Evolus Inc |
| Cannara Biotech |
Evolus and Cannara Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evolus and Cannara Biotech
The main advantage of trading using opposite Evolus and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.| Evolus vs. Crinetics Pharmaceuticals | Evolus vs. Enanta Pharmaceuticals | Evolus vs. Amicus Therapeutics | Evolus vs. Connect Biopharma Holdings |
| Cannara Biotech vs. Holloman Energy Corp | Cannara Biotech vs. cbdMD Inc | Cannara Biotech vs. Evolus Inc | Cannara Biotech vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |